New Century Financial Group LLC Acquires Shares of 35,927 Bath & Body Works, Inc. $BBWI

Key Points

• New Century Financial Group LLC acquired 35,927 shares of Bath & Body Works, Inc. ($BBWI) for approximately $1,076,000 during Q2, highlighting increased interest from institutional investors in the company.
• Bath & Body Works reported Q2 earnings per share of $0.37, matching analysts' expectations, and had revenues of $1.55 billion which is a slight decrease from the previous year.
• The company recently declared a quarterly dividend of $0.20, yielding 3.1%, and having a payout ratio of 23.74%.

New Century Financial Group LLC bought a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) during the second quarter, according to its most recent filing with the SEC. The fund bought 35,927 shares of the company's stock, valued at approximately $1,076,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. SVB Wealth LLC purchased a new stake in Bath & Body Works during the first quarter worth about $35,000. Geneos Wealth Management Inc. grew its position in shares of Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company's stock valued at $35,000 after acquiring an additional 801 shares during the period. Parallel Advisors LLC grew its position in shares of Bath & Body Works by 63.3% during the 2nd quarter. Parallel Advisors LLC now owns 1,241 shares of the company's stock valued at $37,000 after acquiring an additional 481 shares during the period. Golden State Wealth Management LLC increased its stake in shares of Bath & Body Works by 94.7% during the 1st quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock worth $40,000 after purchasing an additional 642 shares during the last quarter. Finally, UMB Bank n.a. raised its holdings in shares of Bath & Body Works by 65.9% in the 1st quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock worth $46,000 after purchasing an additional 596 shares during the period. 95.14% of the stock is owned by hedge funds and other institutional investors.

Bath & Body Works Stock Performance

Shares of NYSE:BBWI opened at $25.69 on Friday. The firm has a fifty day moving average of $28.53 and a 200 day moving average of $29.50. Bath & Body Works, Inc. has a 52-week low of $24.93 and a 52-week high of $41.87. The firm has a market capitalization of $5.30 billion, a PE ratio of 7.62, a price-to-earnings-growth ratio of 0.87 and a beta of 1.52.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings data on Thursday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.37. The firm had revenue of $1.55 billion during the quarter, compared to analysts' expectations of $1.55 billion. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The company's revenue for the quarter was down .8% compared to the same quarter last year. During the same period in the prior year, the business earned $0.37 EPS. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, sell-side analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 5th. Stockholders of record on Friday, August 22nd were issued a $0.20 dividend. The ex-dividend date was Friday, August 22nd. This represents a $0.80 annualized dividend and a dividend yield of 3.1%. Bath & Body Works's payout ratio is currently 23.74%.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on BBWI shares. Telsey Advisory Group reissued an "outperform" rating and issued a $38.00 price objective on shares of Bath & Body Works in a report on Thursday, August 28th. Citigroup cut their price objective on shares of Bath & Body Works from $42.00 to $40.00 and set a "buy" rating for the company in a report on Tuesday, August 19th. Morgan Stanley reduced their price objective on shares of Bath & Body Works from $19.00 to $18.00 and set an "overweight" rating for the company in a research note on Friday, September 12th. Barclays increased their target price on Bath & Body Works from $30.00 to $32.00 and gave the stock an "equal weight" rating in a research report on Friday, August 29th. Finally, Wall Street Zen lowered Bath & Body Works from a "buy" rating to a "hold" rating in a report on Saturday, August 9th. Twelve investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $39.69.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.